Inpatient diabetes control: Approaches to treatment

Diabetes Care

Volumn 27, Issue 9, 2004, Pages 2272-2277

  Bloomgarden, Zachary T ^a,b  

^a Mount Sinai School of Medicine ^*

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN GLARGINE; POTASSIUM;

BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIAGNOSTIC ERROR; DOSE CALCULATION; DRUG DOSE REGIMEN; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HOSPITAL COST; HOSPITAL INFORMATION SYSTEM; HOSPITAL MANAGEMENT; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEFICIENCY; INSULIN SENSITIVITY FACTOR; INSULIN TREATMENT; LENGTH OF STAY; MEDICATION ERROR; NURSE ATTITUDE; PATIENT SAFETY; PHYSICIAN ATTITUDE; PRESCRIPTION; REVIEW; SAFETY; SELF MEDICATION; SLIDING SCALE METHOD; SUPPLEMENTAL INSULIN TREATMENT; TREATMENT INDICATION;

BLOOD GLUCOSE; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INPATIENTS;

EID: 4444317197     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.9.2272     Document Type: Review

References (34)

1. Scarlett JA, Gray RS, Griffin J, Olefsky JM, Kolterman OG: Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care 5:353-363, 1982
2. Van den Berghe G, de Zegher F, Bouillon R: Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83:1827-1834, 1998
3. Oliver MF, Opie LH: Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343:155-158, 1994
4. Jouven X, Charles MA, Desnos M, Ducimetiere P: Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104:756-761, 2001
5. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD: Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100:1230-1239, 1997
6. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, Dandona P: Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52:2882-2887, 2003
7. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 98: 894-898, 1996
8. Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN, Johansen M, Kucik DF, Quon MJ, Draznin B: Inhibition of phosphatidy linositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 277:1794-1799, 2002
9. Dandona P, Aljada A: A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. Am J Cardiol 90:27G-33G, 2002
10. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P: Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109:849-854, 2004
11. Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B: Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ Res 87:746-752, 2000
12. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072, 2002
13. Hogan P, Dall T, Nikolov P, American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932, 2003
14. Levetan CS, Salas JR, Wilets IF, Zumoff B: Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med 99:22-28, 1995
15. Koproski J, Pretto Z, Poretsky L: Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 20:1553-1555, 1997
16. Levetan CS, Passaro MD, Jablonski KA, Ratner RE: Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care 22:1790-1795, 1999
17. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR: Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59:67-71, 2002
18. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr: Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 75: 1392-1399, 2003
19. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K: Association between hyperglycemia and the noreflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41:1-7, 2003
20. Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 290:2041-2047, 2003
21. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471-1478, 2003
22. Fumary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007-1021, 2003
23. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367, 2001
24. Markovitz LJ, Wiechmann RJ, Harris N, Hayden V, Cooper J, Johnson G, Harelstad R, Calkins L, Braithwaite SS: Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract 8:10-18, 2002
25. White NH, Skor D, Santiago JV: Practical closed-loop insulin delivery: a system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med 97:210-213, 1982
26. Mao CS, Riegelhuth ME, Van Gundy D, Cortez C, Melendez S, Ipp E: An overnight insulin infusion algorithm provides morning normoglycemia and can be used to predict insulin requirements in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:2466-2470, 1997
27. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB, American Diabetes Association Diabetes in Hospitals Writing Committee: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27:553-597, 2004
28. Park RH, Hansell DT, Davidson LE, Henderson G, Legge V, Gray GR: Management of diabetic patients requiring nutritional support. Nutrition 8:316-320, 1992
29. Queale WS, Seidler AJ, Brancati FL: Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 157:545-552, 1997
30. Hellman R, Regan J, Rosen H: Effect of intensive, treatment of diabetes of the risk of death or renal failure in NIDDM and IDDM. Diabetes Care 20:258-264, 1997
31. Stagnaro-Green A, Barton MK, Linekin PL, Corkery E, deBeer K, Roman SH: Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt Sinai J Med 62:422-426, 1995
32. Shilo S, Berezovsky S, Friedlander Y, Sonnenblick M: Hypoglycemia in hospitalized nondiabetic older patients. J Am Geriatr Soc 46:978-982, 1998
33. Kagansky N, Levy S, Rimon E, Cojocaru L, Fridman A, Ozer Z, Knobler H: Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med 163:1825-1829, 2003
34. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982, 2002